Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs587778720
rs587778720
0.010 GeneticVariation BEFREE One tumor showed a G to C transversion at p53 codon 213 (arginine to proline), and another showed deletion of the entire gene. 1559227

1992

dbSNP: rs1057519992
rs1057519992
0.020 GeneticVariation BEFREE One tumor had an arginine to histidine substitution at position 175, and one tumor had a glycine to aspartic acid substitution at position 245. 1913660

1991

dbSNP: rs1057520001
rs1057520001
0.010 GeneticVariation BEFREE No point mutation but a codon 31ser-->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese. 7606201

1995

dbSNP: rs886039484
rs886039484
0.010 GeneticVariation BEFREE No point mutation but a codon 31ser-->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese. 7606201

1995

dbSNP: rs28934576
rs28934576
0.780 GeneticVariation BEFREE All three follicular cell lines, however, and the original tumor tissue showed the same p53 mutation (R273H) in MOH analysis and TGGE. 7725741

1995

dbSNP: rs121912651
rs121912651
0.760 GeneticVariation BEFREE We show results that indicate that expression of these specific ribosomal protein genes is increased in the presence of the R248W p53 mutant, which provides a mechanism for their overexpression in human tumors. 10566557

1999

dbSNP: rs587780070
rs587780070
0.010 GeneticVariation BEFREE One of the earliest genetic aberrations is a missense mutation of codon 179 (His179Asn) in the tumor suppressor gene TP53 leading to outgrowth of a cell type expressing only the mutant form of TP53. 10616528

2000

dbSNP: rs28934578
rs28934578
0.780 GeneticVariation BEFREE To understand the relevance of p53 missense mutations in vivo, we generated a mouse containing an arg-to-his substitution at p53 amino acid 172, which corresponds to the R175H hot-spot mutation in human tumors by homologous recombination. 10760284

2000

dbSNP: rs28934578
rs28934578
T 0.780 GeneticVariation CLINVAR Role of the p53-homologue p73 in E2F1-induced apoptosis. 11101847

2000

dbSNP: rs28934571
rs28934571
0.050 GeneticVariation BEFREE Our data revealed a relationship between chromosome 16q homozygous deletions and R249S</span> p53 mutations in tumors where the patient had been exposed to aflatoxin B1 (P=0.002). 11526514

2001

dbSNP: rs121912664
rs121912664
0.100 GeneticVariation BEFREE In conclusion, the germ line Arg337His mutation of p53 protein is present at a high frequency (77.7%) in children with benign or malignant sporadic adrenocortical tumors, but it is not restricted to the pediatric group, since 13.5% of adults with adrenocortical tumors also had this mutation. 11600572

2001

dbSNP: rs28934576
rs28934576
0.780 GeneticVariation BEFREE In contrast to the endometrioid-type tumor, all 3 mutations in 5 serous-type tumors (R273H, 9-bp deletion in codons 240-243, and R248W) showed dominant-negative capacity and presented in a homozygous state in the tumors, indicating a complete functional inactivation. 11733960

2001

dbSNP: rs121912651
rs121912651
0.760 GeneticVariation BEFREE In contrast to the endometrioid-type tumor, all 3 mutations in 5 serous-type tumors (R273H, 9-bp deletion in codons 240-243, and R248W) showed dominant-negative capacity and presented in a homozygous state in the tumors, indicating a complete functional inactivation. 11733960

2001

dbSNP: rs1555526711
rs1555526711
0.010 GeneticVariation BEFREE One tumour with a single base deletion in the N-terminus (codon 8) of the CDKN2A/p16(INK4a) gene carried a novel germ-line mutation or a rare polymorphism (Ile51Met) in exon 2 of the CDK4 gene. 11960918

2002

dbSNP: rs869054324
rs869054324
0.010 GeneticVariation BEFREE One tumour with a single base deletion in the N-terminus (codon 8) of the CDKN2A/p16(INK4a) gene carried a novel germ-line mutation or a rare polymorphism (Ile51Met) in exon 2 of the CDK4 gene. 11960918

2002

dbSNP: rs371409680
rs371409680
0.020 GeneticVariation BEFREE Functional analysis of the p53 alleles present in the patient's tumor indicated that the germ-line p53(R283H) could transactivate the CDKN1A((p21, WAF1, cip1, SDI1)) but not the BAX gene and retained the ability to induce growth arrest of human glioblastoma cells. 12019170

2002

dbSNP: rs751477326
rs751477326
0.010 GeneticVariation BEFREE There was no difference between cases with and without histologically proven nodal disease with regard to integration status of HPV-16 DNA in the primary tumour (integrated 90.9% vs 71.4%, episomal 9.1% vs 21.4%, mixed 0% vs 7.1%) and p53 codon 72 polymorphism (Arg/Arg 54.5% vs 67.9%, Pro/Pro 0 vs 7.1%, Arg/Pro 45.5% vs 21.4%). 12618167

2003

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE We identified the presence of LOH at 17p13 and Pro72Arg polymorphism in tumor DNA. 12684657

2003

dbSNP: rs1131691014
rs1131691014
0.100 GeneticVariation BEFREE We identified the presence of LOH at 17p13 and Pro72Arg polymorphism in tumor DNA. 12684657

2003

dbSNP: rs878854066
rs878854066
0.100 GeneticVariation BEFREE We identified the presence of LOH at 17p13 and Pro72Arg polymorphism in tumor DNA. 12684657

2003

dbSNP: rs776167460
rs776167460
0.010 GeneticVariation BEFREE In the tumor carrying G40S, other somatic hMSH2 mutations, G203R and 687delA in the (A)(7) repeat, and 5 one-bp deletions in the target genes were found, while no mutation in the p53 and K-ras genes. 12792735

2004

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE Statistically significant associations were noted between SNPs in beta-catenin and APOE and a positive family history of cancer (beta-catenin: p=0.034, APOE: p=0.033); tumor location and a DCC SNP (p=0.038) and the P53 R72P mutation and survival (p=0.0336). 15523694

2005

dbSNP: rs1131691014
rs1131691014
0.100 GeneticVariation BEFREE Statistically significant associations were noted between SNPs in beta-catenin and APOE and a positive family history of cancer (beta-catenin: p=0.034, APOE: p=0.033); tumor location and a DCC SNP (p=0.038) and the P53 R72P mutation and survival (p=0.0336). 15523694

2005

dbSNP: rs878854066
rs878854066
0.100 GeneticVariation BEFREE Statistically significant associations were noted between SNPs in beta-catenin and APOE and a positive family history of cancer (beta-catenin: p=0.034, APOE: p=0.033); tumor location and a DCC SNP (p=0.038) and the P53 R72P mutation and survival (p=0.0336). 15523694

2005

dbSNP: rs121912664
rs121912664
0.100 GeneticVariation BEFREE Deletion mapping of chromosome 17 in benign and malignant adrenocortical tumors associated with the Arg337His mutation of the p53 tumor suppressor protein. 15741269

2005